Corrigendum: Efficacy and Safety of CAR-T Cell Products Axicabtagene Ciloleucel, Tisagenlecleucel, and Lisocabtagene Maraleucel for the Treatment of Hematologic Malignancies: A Systematic Review and Meta-Analysis
| الحاوية / القاعدة: | Frontiers in Oncology |
|---|---|
| المؤلفون الرئيسيون: | , , , , , , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
Frontiers Media S.A.
2021-10-01
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://www.frontiersin.org/articles/10.3389/fonc.2021.768128/full |
| _version_ | 1852771748693409792 |
|---|---|
| author | Jun Meng XiaoQin Wu Zhen Sun RenDe Xun MengSi Liu Rui Hu JianChao Huang |
| author_facet | Jun Meng XiaoQin Wu Zhen Sun RenDe Xun MengSi Liu Rui Hu JianChao Huang |
| author_sort | Jun Meng |
| collection | DOAJ |
| container_title | Frontiers in Oncology |
| format | Article |
| id | doaj-art-e8d6016496c6449bbbc45aac00a758c9 |
| institution | Directory of Open Access Journals |
| issn | 2234-943X |
| language | English |
| publishDate | 2021-10-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| spelling | doaj-art-e8d6016496c6449bbbc45aac00a758c92025-08-19T20:51:40ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-10-011110.3389/fonc.2021.768128768128Corrigendum: Efficacy and Safety of CAR-T Cell Products Axicabtagene Ciloleucel, Tisagenlecleucel, and Lisocabtagene Maraleucel for the Treatment of Hematologic Malignancies: A Systematic Review and Meta-AnalysisJun Meng0XiaoQin Wu1Zhen Sun2RenDe Xun3MengSi Liu4Rui Hu5JianChao Huang6Molecular Genetics Laboratory, Suining Central Hospital, Suining, ChinaDepartment of Neurosurgery, The First Affiliated Hospital, University of South China, Hengyang, ChinaHengyang Medical College, University of South China, Hengyang, ChinaDepartment of Neurosurgery, The First Affiliated Hospital, University of South China, Hengyang, ChinaHengyang Medical College, University of South China, Hengyang, ChinaHengyang Medical College, University of South China, Hengyang, ChinaDepartment of Neurosurgery, The First Affiliated Hospital, University of South China, Hengyang, Chinahttps://www.frontiersin.org/articles/10.3389/fonc.2021.768128/fullchimeric antigen receptor T-cell productCAR-T cell therapyimmunotherapylymphomaleukemiahematologic malignancy |
| spellingShingle | Jun Meng XiaoQin Wu Zhen Sun RenDe Xun MengSi Liu Rui Hu JianChao Huang Corrigendum: Efficacy and Safety of CAR-T Cell Products Axicabtagene Ciloleucel, Tisagenlecleucel, and Lisocabtagene Maraleucel for the Treatment of Hematologic Malignancies: A Systematic Review and Meta-Analysis chimeric antigen receptor T-cell product CAR-T cell therapy immunotherapy lymphoma leukemia hematologic malignancy |
| title | Corrigendum: Efficacy and Safety of CAR-T Cell Products Axicabtagene Ciloleucel, Tisagenlecleucel, and Lisocabtagene Maraleucel for the Treatment of Hematologic Malignancies: A Systematic Review and Meta-Analysis |
| title_full | Corrigendum: Efficacy and Safety of CAR-T Cell Products Axicabtagene Ciloleucel, Tisagenlecleucel, and Lisocabtagene Maraleucel for the Treatment of Hematologic Malignancies: A Systematic Review and Meta-Analysis |
| title_fullStr | Corrigendum: Efficacy and Safety of CAR-T Cell Products Axicabtagene Ciloleucel, Tisagenlecleucel, and Lisocabtagene Maraleucel for the Treatment of Hematologic Malignancies: A Systematic Review and Meta-Analysis |
| title_full_unstemmed | Corrigendum: Efficacy and Safety of CAR-T Cell Products Axicabtagene Ciloleucel, Tisagenlecleucel, and Lisocabtagene Maraleucel for the Treatment of Hematologic Malignancies: A Systematic Review and Meta-Analysis |
| title_short | Corrigendum: Efficacy and Safety of CAR-T Cell Products Axicabtagene Ciloleucel, Tisagenlecleucel, and Lisocabtagene Maraleucel for the Treatment of Hematologic Malignancies: A Systematic Review and Meta-Analysis |
| title_sort | corrigendum efficacy and safety of car t cell products axicabtagene ciloleucel tisagenlecleucel and lisocabtagene maraleucel for the treatment of hematologic malignancies a systematic review and meta analysis |
| topic | chimeric antigen receptor T-cell product CAR-T cell therapy immunotherapy lymphoma leukemia hematologic malignancy |
| url | https://www.frontiersin.org/articles/10.3389/fonc.2021.768128/full |
| work_keys_str_mv | AT junmeng corrigendumefficacyandsafetyofcartcellproductsaxicabtageneciloleuceltisagenlecleucelandlisocabtagenemaraleucelforthetreatmentofhematologicmalignanciesasystematicreviewandmetaanalysis AT xiaoqinwu corrigendumefficacyandsafetyofcartcellproductsaxicabtageneciloleuceltisagenlecleucelandlisocabtagenemaraleucelforthetreatmentofhematologicmalignanciesasystematicreviewandmetaanalysis AT zhensun corrigendumefficacyandsafetyofcartcellproductsaxicabtageneciloleuceltisagenlecleucelandlisocabtagenemaraleucelforthetreatmentofhematologicmalignanciesasystematicreviewandmetaanalysis AT rendexun corrigendumefficacyandsafetyofcartcellproductsaxicabtageneciloleuceltisagenlecleucelandlisocabtagenemaraleucelforthetreatmentofhematologicmalignanciesasystematicreviewandmetaanalysis AT mengsiliu corrigendumefficacyandsafetyofcartcellproductsaxicabtageneciloleuceltisagenlecleucelandlisocabtagenemaraleucelforthetreatmentofhematologicmalignanciesasystematicreviewandmetaanalysis AT ruihu corrigendumefficacyandsafetyofcartcellproductsaxicabtageneciloleuceltisagenlecleucelandlisocabtagenemaraleucelforthetreatmentofhematologicmalignanciesasystematicreviewandmetaanalysis AT jianchaohuang corrigendumefficacyandsafetyofcartcellproductsaxicabtageneciloleuceltisagenlecleucelandlisocabtagenemaraleucelforthetreatmentofhematologicmalignanciesasystematicreviewandmetaanalysis |